LINK:  https://bswhealth.webex.com/bswhealth/j.php?MTID=mb4390d7d3d7d379c0a483f2f1b99ee51

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) Describe the process of UK liver transplant scheme based on transplant benefit, (2) Discuss the benefits and risks of benefit-based allocation, (3) Identify the differences between UK and US liver graft allocation.

FACULTY DISCLOSURE:  Ian Rowe, MBChB, MRCP (UK), PhD, was an advisor for Boehringer Ingelheim and Roche Companies.

PLANNER DISCLOSURE: James Trotter, MD, Sumeet Asrani, MD, Gregory McKenna, MD, and Kathy Brown, RN, CCTC, have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CEPTC Credit: The American Board for Transplant Certification (ABTC) has been applied for educational offering for up to 1 Category 1 Continuing Education Point for Transplant Certification (CEPTCs).

For information, please contact Karina Pena at karina.pena@bswhealth.org